Initial findings indicate that the COVID-19 Omicron variant might be less deadly than expected. The market will likely continue its upward trend. So, we think it could be wise to bet on cheap yet quality stocks Teva Pharmaceutical (TEVA), Himax Technologies (NASDAQ:), YPF Sociedad Anónima (YPF), and LexinFintech Holdings (LX). Both stocks are trading at very affordable prices. You can read more about these names by reading the following. Investor sentiment has been lowered due to the new COVID-19 Omicron variant. Global markets are showing weakness. Although initial results suggest that this variant might have mild effects, experts still believe that it won’t stop the U.S. recovery. According to Marc Chandler, chief market strategist at Bannockburn Global Forex, “People feel a bit more confident that while the new variant might be highly contagious, it looks like so far the conditions are mild.”

In addition, concerning the mildness of the variant’s effects, Investor Bill Ackman said, “If this turns out to be true, this is bullish, not bearish for markets.” This represents a positive outlook for the overall market at this juncture, and thereby, quality stocks trading at affordable prices could be wise bets now.

Fundamentally strong stocks Teva Pharmaceutical Industries Limited (NYSE:), Himax Technologies, Inc. (HIMX), YPF Sociedad Anónima (YPF), and LexinFintech Holdings Ltd. (LX), are currently trading at less than $15 per share and could be potential outperformers.

Continue reading on StockNews